In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by β-TCP nanoparticles

References

• Chen W, Zheng R, Zhang S, et al. Annual report on status of cancer in China, 2010. Chin J Cancer Res. 2014;26(1):48–58. doi:10.3978/j.issn.1000-9604.2014.01.0824653626
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27(1):2–12. doi:10.3978/j.issn.1000-9604.2015.01.0625717220
   PubMed Web of Science ®Google Scholar
• Yau T, Tang VYF, Yao TJ, Fan ST, Lo CM, Poon RTP. Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146(7):1691–1700.e1693. doi:10.1053/j.gastro.2014.02.03224583061
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zhang S, et al. Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 2013;25(1):10–21. doi:10.3978/j.issn.1000-9604.2012.12.0423372337
   PubMedGoogle Scholar
• Chapman S, Dobrovolskaia M, Farahani K, et al. Nanoparticles for cancer imaging: the good, the bad, and the promise. Nano Today. 2013;8(5):454–460. doi:10.1016/j.nantod.2013.06.00125419228
   PubMed Web of Science ®Google Scholar
• Cao B, Yang M, Zhu Y, Qu X, Mao C. Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy. Adv Mater. 2014;26(27):4627–4631. doi:10.1002/adma.20140155024890678
   PubMed Web of Science ®Google Scholar
• Fiorillo M, Verre AF, Iliut M, et al. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via “differentiation-based nano-therapy”. Oncotarget. 2015;6(6):3553–3562. doi:10.18632/oncotarget.334825708684
   PubMedGoogle Scholar
• Selim ME, Hendi AA. Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells. Asian Pac J Cancer Prev. 2012;13(4):1617–1620.22799377
   PubMedGoogle Scholar
• Zhang L, Wang L, Hu Y, et al. Selective metabolic effects of gold nanorods on normal and cancer cells and their application in anticancer drug screening. Biomaterials. 2013;34(29):7117–7126. doi:10.1016/j.biomaterials.2013.05.04323787109
   PubMedGoogle Scholar
• Gobbo OL, Sjaastad K, Radomski MW, Volkov Y, Prina-Mello A. Magnetic nanoparticles in cancer theranostics. Theranostics. 2015;5(11):1249–1263. doi:10.7150/thno.1154426379790
   PubMed Web of Science ®Google Scholar
• Lima-Tenório MK, Gómez Pineda EA, Ahmad NM, Fessi H, Elaissari A. Magnetic nanoparticles: in vivo cancer diagnosis and therapy. Int J Pharm. 2015;493(1):313–327. doi:10.1016/j.ijpharm.2015.07.05926232700
   PubMedGoogle Scholar
• Zhang Q, Wang X, Li PZ, et al. Biocompatible, uniform, and redispersible mesoporous silica nanoparticles for cancer‐targeted drug delivery in vivo. Adv Funct Mater. 2014;24(17):2450–2461. doi:10.1002/adfm.201302988
   Web of Science ®Google Scholar
• Choi S, Coonrod S, Estroff L, Fischbach C. Chemical and physical properties of carbonated HA affect breast cancer cell behavior. Acta Biomater. 2015;24:333–342. doi:10.1016/j.actbio.2015.06.00126072364
   PubMedGoogle Scholar
• Chu SH, Karri S, Ma YB, Feng DF, Li ZQ. In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles. Neuro-Oncology. 2013;15(7):880. doi:10.1093/neuonc/not03023519742
   PubMedGoogle Scholar
• Liang C, Diao S, Wang C, et al. Tumor metastasis inhibition by imaging‐guided photothermal therapy with single‐walled carbon nanotubes. Adv Mater. 2014;26(32):5646–5652. doi:10.1002/adma.20140182524924258
   PubMedGoogle Scholar
• Lin W, Huang Y-W, X-D Z, Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006;217(3):252–259. doi:10.1016/j.taap.2006.10.00417112558
   PubMed Web of Science ®Google Scholar
• Liu S, Xu L, Zhang T, Ren G, Yang Z. Oxidative stress and apoptosis induced by nanosized titanium dioxide in PC12 cells. Toxicology. 2010;267(1):172–177. doi:10.1016/j.tox.2009.11.01219922763
   PubMedGoogle Scholar
• Xu M, Huang N, Xiao Z, Lu Z. Photoexcited TiO2 nanoparticles through •OH-radicals induced malignant cells to necrosis. Supramolecular Sci. 1998;5(5):449–451. doi:10.1016/S0968-5677(98)00048-0
   Google Scholar
• Qiu-Lian QU, Zhang YG. Effects of three kinds of nanoparticles on the mitochondrial membrane potential and level of reactive oxygen species in human gastric carcinoma cell line BGC-823. Bull Acad Mil Med Sci. 2010;34(4):306–309.
   Google Scholar
• Ma M. Preparation of magnetite nanoparticles and interaction with cancer cells. J Southeast Univ. 2003;33(2):205–207.
   Google Scholar
• Laurent S, Saei AA, Behzadi S, Panahifar A, Mahmoudi M. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin Drug Deliv. 2014;11(9):1449–1470. doi:10.1517/17425247.2014.92450124870351
   PubMed Web of Science ®Google Scholar
• Tang W, Yuan Y, Liu C, Wu Y, Lu X, Qian J. Differential cytotoxicity and particle action of hydroxyapatite nanoparticles in human cancer cells. Nanomedicine. 2014;9(3):397. doi:10.2217/nnm.12.21723614636
   PubMed Web of Science ®Google Scholar
• Yuan Y, Liu C, Qian J, Wang J, Zhang Y. Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials. 2010;31(4):730–740. doi:10.1016/j.biomaterials.2009.09.08819836072
   PubMed Web of Science ®Google Scholar
• Meena R, Kesari KK, Rani M, Paulraj R. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human breast cancer cells (MCF-7). J Nanopart Res. 2012;14(2):712. doi:10.1007/s11051-011-0712-5
   Web of Science ®Google Scholar
• Olton DYE, Close JM, Sfeir CS, Kumta PN. Intracellular trafficking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particles. Biomaterials. 2011;32(30):7662–7670. doi:10.1016/j.biomaterials.2011.01.04321774979
   PubMedGoogle Scholar
• Sykes EA, Chen J, Zheng G, Chan WCW. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano. 2014;8(6):5696–5706. doi:10.1021/nn500299p24821383
   PubMed Web of Science ®Google Scholar
• Bañobre-López M, Teijeiro A, Rivas J. Magnetic nanoparticle-based hyperthermia for cancer treatment. Rep Pract Oncol Radiother. 2013;18(6):397–400. doi:10.1016/j.rpor.2013.09.01124416585
   PubMedGoogle Scholar
• Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145. doi:10.1038/nnano.2008.3018654486
   PubMed Web of Science ®Google Scholar
• Xu J, Xu P, Li Z, Huang J, Yang Z. Oxidative stress and apoptosis induced by hydroxyapatite nanoparticles in C6 cells. J Biomed Mater Res A. 2012;100A(3):738–745. doi:10.1002/jbm.a.v100a.3
   Web of Science ®Google Scholar
• Elshafie H, Armentano M, Carmosino M, Bufo S, De Feo V, Camele I. Cytotoxic activity of origanum vulgare l. on hepatocellular carcinoma cell line hepg2 and evaluation of its biological activity. Molecules. 2017;22(9):1435. doi:10.3390/molecules22091435
   PubMed Web of Science ®Google Scholar
• Sanosh KP, Chu M-C, Balakrishnan A, Kim TN, Cho S-J. Sol–gel synthesis of pure nano sized β-tricalcium phosphate crystalline powders. Curr Appl Phys. 2010;10(1):68–71. doi:10.1016/j.cap.2009.04.014
   Web of Science ®Google Scholar
• Koshkaki MR, Ghassai H, Khavandi A, Seyfoori A, Molazemhosseini A. Effects of formaldehyde solution and nanoparticles on mechanical properties and biodegradation of gelatin/nano β-TCP scaffolds. Iran Polym J. 2013;22(9):653–664. doi:10.1007/s13726-013-0164-0
   Web of Science ®Google Scholar
• Yin M, Yin Y, Han Y, Dai H, Li S. Effects of uptake of hydroxyapatite nanoparticles into hepatoma cells on cell adhesion and proliferation. J Nanomater. 2014;2014(2014):1–7.
   Google Scholar
• Hu L, Mao Z, Gao C. Colloidal particles for cellular uptake and delivery. J Mater Chem. 2009;19(20):3108–3115. doi:10.1039/b815958k
   Web of Science ®Google Scholar
• Motskin M, Wright DM, Muller K, et al. Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials. 2009;30(19):3307–3317. doi:10.1016/j.biomaterials.2009.02.04419304317
   PubMed Web of Science ®Google Scholar
• Cai Y, Liu Y, Yan W, et al. Role of hydroxyapatite nanoparticle size in bone cell proliferation. J Mater Chem. 2007;17(36):3780–3787. doi:10.1039/b705129h
   Web of Science ®Google Scholar
• Han Y, Li S, Cao X, et al. Different inhibitory effect and mechanism of hydroxyapatite nanoparticles on normal cells and cancer cells in vitro and in vivo. Sci Rep. 2014;4(3):7134. doi:10.1038/srep0713425409543
   PubMedGoogle Scholar
• Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol. 2006;121(2):144–158. doi:10.1016/j.clim.2006.06.01016904380
   PubMed Web of Science ®Google Scholar
• Daniels TR, Delgado T, Helguera G, Penichet ML. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol. 2006;121(2):159–176. doi:10.1016/j.clim.2006.06.00616920030
   PubMed Web of Science ®Google Scholar
• Martin CL, Bouvard D, Delette G. Discrete element simulations of the compaction of aggregated ceramic powders. J Am Ceram Soc. 2006;89(11):3379–3387. doi:10.1111/jace.2006.89.issue-11
   Web of Science ®Google Scholar
• Huang H-L, Fang L-W, Lu S-P, Chou C-K, Luh T-Y, Lai M-Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene. 2003;22:8168. doi:10.1038/sj.onc.120697914603257
   PubMed Web of Science ®Google Scholar
• Asharani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279–290. doi:10.1021/nn800596w19236062
   PubMed Web of Science ®Google Scholar
• Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85(7):743–750. doi:10.1007/s00204-010-0545-520428844
   PubMed Web of Science ®Google Scholar
• Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422–426. doi:10.1038/1888410201372
   PubMed Web of Science ®Google Scholar
• Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2013;15:49. doi:10.1038/nrm3722
   Web of Science ®Google Scholar
• Wang Y, Wang J, Hao H, et al. In vitro and in vivo mechanism of bone tumor inhibition by selenium-doped bone mineral nanoparticles. ACS Nano. 2016;10(11):9927–9937. doi:10.1021/acsnano.6b0383527797178
   PubMedGoogle Scholar